Cargando…
A Case of Nonfunctioning Pituitary Carcinoma That Responded to Temozolomide Treatment
Pituitary carcinoma is a rare malignancy and is difficult to manage. Pituitary carcinomas commonly produce either PRL or ACTH, but some do not produce pituitary hormones. The alkylating reagent temozolomide (TMZ) was recently shown to be effective as a treatment for pituitary carcinoma. Most of the...
Autores principales: | Morokuma, Haruko, Ando, Takao, Hayashida, Takuya, Horie, Ichiro, Inoshita, Naoko, Murata, Fumi, Ueki, Ikuko, Nakamura, Kan, Imaizumi, Misa, Usa, Toshiro, Kawakami, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472534/ https://www.ncbi.nlm.nih.gov/pubmed/23091742 http://dx.doi.org/10.1155/2012/645914 |
Ejemplares similares
-
Temozolomide and Capecitabine Treatment for an Aggressive Somatotroph Pituitary Tumor: A Case Report and Literature Review
por: Ishida, Atsushi, et al.
Publicado: (2022) -
Immunohistochemical Profile of Nonfunctioning Pituitary Adenomas
por: Solovey, Mariana, et al.
Publicado: (2021) -
Clinical evaluations of pituitary apoplexy in incidental nonfunctional pituitary adenomas
por: Takeshita, Kaori, et al.
Publicado: (2022) -
SAT-301 Relationship Between Clinicopathological Aspects and MSH6/MSH2 and PD-L1 Expressions in Clinically Nonfunctioning Pituitary Adenomas
por: Uraki, Shinsuke, et al.
Publicado: (2020) -
Nonfunctioning giant pituitary adenomas: Invasiveness and recurrence
por: Landeiro, José Alberto, et al.
Publicado: (2015)